본문으로 건너뛰기
← 뒤로

Changes in peripheral blood B cell levels predict overall survival in patients with advanced liver cancer treated with immune target inhibitors.

1/5 보강
Discover oncology 📖 저널 OA 94.5% 2022: 2/2 OA 2023: 3/3 OA 2024: 36/36 OA 2025: 546/546 OA 2026: 293/344 OA 2022~2026 2025 Vol.17(1) p. 79
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: higher B-cell proportions or absolute counts had significantly longer overall survival (OS) and progression-free survival (PFS)
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Multivariate analysis confirmed elevated B-cell proportion as an independent protective factor for OS. These results suggest that peripheral blood B-cell levels may serve as prognostic biomarkers for PD-1-based immunotherapy in advanced HCC.

Cheng S, Tang J, Mo Y, Wu N

📝 환자 설명용 한 줄

PD-1 inhibitors show efficacy in hepatocellular carcinoma (HCC), yet overall outcomes remain poor.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Cheng S, Tang J, et al. (2025). Changes in peripheral blood B cell levels predict overall survival in patients with advanced liver cancer treated with immune target inhibitors.. Discover oncology, 17(1), 79. https://doi.org/10.1007/s12672-025-04236-x
MLA Cheng S, et al.. "Changes in peripheral blood B cell levels predict overall survival in patients with advanced liver cancer treated with immune target inhibitors.." Discover oncology, vol. 17, no. 1, 2025, pp. 79.
PMID 41364270 ↗

Abstract

PD-1 inhibitors show efficacy in hepatocellular carcinoma (HCC), yet overall outcomes remain poor. In this retrospective study of 258 advanced HCC patients treated between 2019 and 2024, peripheral blood B-cell dynamics were evaluated. Patients with higher B-cell proportions or absolute counts had significantly longer overall survival (OS) and progression-free survival (PFS). Multivariate analysis confirmed elevated B-cell proportion as an independent protective factor for OS. These results suggest that peripheral blood B-cell levels may serve as prognostic biomarkers for PD-1-based immunotherapy in advanced HCC.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기